Skip to main content

Table 1 Suggestive associations of rare variant burden in the ACMG-56 genes with psychiatric disorders

From: Psychiatric manifestations of rare variation in medically actionable genes: a PheWAS approach

Phenotype

PheCode

Gene

Consequence

Ncase

Ncontrol

Ncase carrier

Ncontrol carrier

OR

95% CI

P-value

Major depressive disorder

296.22

PTEN

Non-synonymous

2312

12,869

8

8

9.15

(3.03, 27.6)

1.5 × 10–4

Substance addiction and disorders

316

KCNQ1

Damaging missense

446

14,735

4

10

14.63

(4.31, 49.6)

2.4 × 10–4

Mental retardation

315.3

PKP2

All

123

15,058

5

168

8.32

(3.24, 21.4)

3.0 × 10–4

Major depressive disorder

296.22

LDLR

Non-synonymous

2312

12,869

35

105

2.10

(1.42, 3.11)

3.6 × 10–4

Other mental disorder

306

TNNI3

PTV + damaging mis

1759

13,422

3

0

65.85

(1.90, 2279)

4.2 × 10–4

Depression

296.2

CACNA1S

All

2590

12,591

100

327

1.50

(1.20, 1.88)

5.8 × 10–4

Tobacco use disorder

318

PKP2

PTV + damaging mis

2783

12,398

5

2

15.98

(2.41, 106)

6.7 × 10–4

Substance addiction and disorders

316

KCNQ1

PTV + damaging mis

446

14,735

4

14

10.56

(3.36, 33.2)

7.1 × 10–4

Tobacco use disorder

318

APOB

PTV

2783

12,398

6

2

12.99

(2.19, 76.9)

1.1 × 10–3

Somatoform disorder

303.4

SDHC

PTV

130

15,051

1

1

160.70

(8.64, 2987)

1.1 × 10–3

Alcoholism

317.1

DSC2

PTV

334

14,847

2

3

34.33

(4.68, 252)

1.3 × 10–3

  1. For each gene, a PheWAS was performed to assess the burden of rare variation (MAF < 1%) in 37 mental illnesses (Table S3) using Firth’s logistic regression, adjusting for age, sex, sites, and the first 10 PCs. This analysis was done separately for five groups of qualifying variants (all variants with MAF < 1%, non-synonymous variants, damaging missense variants, protein-truncating variants or PTVs, and PTVs plus damaging missense variants). Shown in the table are suggestive gene-disorder associations at a Bonferroni-corrected significance of 0.05/37 = 1.35 × 10–3 in an individual PheWAS. “Carrier” is defined as individuals who carried at least one copy of the qualifying variant in the gene. No genes achieved study-wide statistical significance at FDR < 0.05 accounting for all tests. The full set of gene-disorder associations are depicted in Fig. 1. OR odds ratio, CI confidence interval